Dr Ehsan Alvandi is a recent PhD graduate and experienced molecular biologist working with the Personalised Immunotherapy Program at MIA. He contributes to the processing of melanoma patient samples for treatment assessment and supports the team’s histopathology research, including tissue microarray requirements. In addition, Dr Alvandi is involved in genomics projects utilising the Genexus platform, helping to advance translational research in personalised immunotherapy.